Simvastatin attenuates neutrophil recruitment in one-lung ventilation model in rats
Acta cir. bras
;
28(4): 245-250, Apr. 2013. graf, tab
Article
Dans Anglais
| LILACS
| ID: lil-670249
ABSTRACT
PURPOSE:
To investigate the anti-inflammatory effects of simvastatin in rats undergoing one-lung ventilation (OLV) followed by lung re-expansion.METHODS:
Male Wistar rats (n=30) were submitted to 1-h OLV followed by 1-h lung re-expansion. Treated group received simvastatin (40 mg/kg for 21 days) previous to OLV protocol. Control group received no treatment or surgical/ventilation interventions. Measurements of pulmonary myeloperoxidase (MPO) activity, pulmonary protein extravasation, and serum levels of cytokines and C-reactive protein (CRP) were performed.RESULTS:
OLV significantly increased the MPO activity in the collapsed and continuously ventilated lungs (31% and 52% increase, respectively) compared with control (p<0.05). Treatment with simvastatin significantly reduced the MPO activity in the continuously ventilated lung but had no effect on lung edema after OLV. The serum IL-6 and CRP levels were markedly higher in OLV group, but simvastatin treatment failed to affect the production of these inflammatory markers. Serum levels of IL-1β, TNF-α and IL-10 remained below the detection limit in all groups.CONCLUSIONS:
In an experimental one-lung ventilation model pre-operative treatment with simvastatin reduces remote neutrophil infiltration in the continuously ventilated lung. Our findings suggest that simvastatin may be of therapeutic value in OLV-induced pulmonary inflammation deserving clinical investigations.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Simvastatine
/
Infiltration par les neutrophiles
/
Ventilation sur poumon unique
/
Anti-inflammatoires
Type d'étude:
Guide de pratique
/
Étude pronostique
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
Acta cir. bras
Thème du journal:
Chirurgie générale
/
Procedimentos Cir£rgicos Operat¢rios
Année:
2013
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
UNICAMP/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS